Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants

PHASE1RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 26, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2027

Conditions
Bronchopulmonary Dysplasia
Interventions
BIOLOGICAL

Human Umbilical Cord Derived-Mesenchymal Stem Cells

Cohort 1 : 3 million cells/kg ; Cohort 2 : 10 million cells/kg ; Cohort 3 : 30 million cells/kg

Trial Locations (1)

Unknown

RECRUITING

National Chen-Kung University Hospital, Tainan City

Sponsors
All Listed Sponsors
lead

Meridigen Biotech Co., Ltd.

INDUSTRY

NCT03631420 - Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants | Biotech Hunter | Biotech Hunter